Haleon Plc (HLN)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Jul 07, 2025

$5.04

P/E Ratio

23.51

Market Cap

$45.41B

Description
Add to research
View more

Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom.

Metrics
Add to research
View more

Overview

  • HQWeybridge, SU
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerHLN
  • Price$5.04261-2.33%

Trading Information

  • Market cap$45.41B
  • Float97.30%
  • Average Daily Volume (1m)14,749,234
  • Average Daily Volume (3m)16,120,549
  • EPS$0.16

Company

  • Revenue$11.23B
  • Rev growth (1yr)-0.61%
  • Net income$1.44B
  • Gross margin62.69%
  • EBITDA margin25.21%
  • EBITDA$2.83B
  • EV$42.56B
  • EV/Revenue3.79
  • P/E23.51
  • P/S3.03
  • P/B2.08
  • Debt/Equity62.64
Documents
Add to research
View more